Question

II. Short Answer - The following questions require either brief lists or 3 or 4 sentence answers at most. For questions that require lists, any incorrect item will be marked as such. That is, if the question asks for three items and you list four, you will not receive credit if one of those four is incorrect.

1. What are some of the concerns related to subsidizing anti-malarial drugs?

Answer 1

Answer:

Concerns related to subsidizing antimalarial drugs:

* subsiding artemisinin based combination therapy(ACT) in antimalarial drugs:

* Randomised trials, non randomised trials studies that compared the effects of ACT prices subsides for private retailers to no subsidies or alternating ACT mechanisms.

* Because of the high cost of some antimalarial drugs they are subsided and low cost drugs are selected which are having same therapeutic efficacy.

* This leads to the decrese the financial burden on patient and and also better treatment.

* In zanzibar and Nigeria the ACT drugs helped drive down sales of one drug treatments.

* Those called monotherapies which are cheaper are a problem because they can spur drug resistant malaria.

* The leverage of an international subsidy of combination therapy discourage the distribution of immunotherapies, the use of which might foster incresing resistance to antimalarial drugs in future.

* The increasing death toll from drug resistant falciparum malaria is cause for international concern.

* The artemisinins are the only first line antimalarial drugs appropriate widespread use that still work against all chloroquine resistant malaria parasites.

* If resistance to artemisinin is allowed to develop and spread before drugs are at hand, malaria's toll could even rise higher.

These are the concerns related to subsidizing antimalarial drugs.